Professional Documents
Culture Documents
Gov. D. Mangubat Ave., Brgy. Burol Main, City of Dasmariñas, Cavite 4114, Philippines
Tel. Nos. (046) 416-4339/41 www.eac.edu.ph
Journal Critiquing
assay was also able to find disease-related -synuclein aggregates. Last but not least,
the RT-QuIC assay proved successful in identifying disease-associated prion
aggregates in skin tissue from Creutzfeldt-Jakob disease patients. The result suggests
that the RT-QuIC test can be a useful tool for the early detection of
neurodegenerative disorders. The assay could be used to determine which patients
are more likely to contract these illnesses, as well as to track the disorders'
development. Therefore, this method can be used for the early diagnosis of
neurodegenerative diseases. The RT-QuIC assay is still in its early stages of
development, but it has the potential to revolutionize the way we diagnose and treat
neurodegenerative diseases.
4. Limitations and possible suggestions to the journal article
- The study contains some kind of limits. First off, the study only used a few samples,
therefore it's crucial to confirm the results in a broader investigation. Second,
because the study was cross-sectional in nature, the researchers were unable to
ascertain what caused the association between protein aggregation and
neurodegenerative disorders. Third, the clinical relevance of the discovered protein
aggregates was not evaluated by the study. It's likely that the protein aggregates that
were found have nothing to do with symptoms of disease. With this limitations,
several suggestions can be done for future research related to the study which
includes conducting a larger study with a more diverse population of patients, using a
longitudinal design to track the progression of protein aggregates over time,
Assessing the clinical significance of protein aggregates by correlating their levels with
clinical symptoms, and developing a treatment that targets protein aggregates.
5. What is the societal impact of the journal article?
- The RT-QuIC assay could also lead to the development of new treatments for
neurodegenerative diseases. If it is possible to target protein aggregates, this could
lead to the development of drugs that can prevent or slow the progression of these
diseases. This could have a major impact on the lives of millions of people who are
affected by neurodegenerative diseases. Researchers can lead the development by
gathering more information through large quantity tests to see if it is totally effective.
Reference:
Saijo, E. (2018). Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-
Synuclein, and Prion Aggregates Protein Misfolding Diseases, 19–37. Doi: 10.1007/978-1-
4939-8820-4_2